Skip to main navigation Skip to search Skip to main content

3D-printed solid oral dosage forms for mental and neurological disorders: recent advances and future perspectives

  • Monika Wojtyłko
  • , Dimitrios A. Lamprou*
  • , Anna Froelich
  • , Wiesław Kuczko
  • , Radosław Wichniarek
  • , Tomasz Osmałek*
  • *Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

270 Downloads (Pure)

Abstract

3D printing (3DP) applications in medicine are intensively investigated, creating an opportunity to provide patient-tailored therapy by delivering a drug with an accurate dose and release profile. Moving away from the 'one size fits all' paradigm, it could be beneficial for treating mental and neurological disorders, improving the efficiency and safety of the therapy. The aim of this critical review is to assess recent advances and identify gaps regarding 3DP in this important and challenging field, by focusing on recent research examples. Applications of the 3DP techniques for solid dosage forms in mental and neurological disorders have been covered and discussed, together with recent advantages, limitations, and future directions. The personalize treatment, which is considered as the most significant advantage of the 3DP technique, can be beneficial in mental and neurological disorders therapy, where the dose should be adjusted to the patient. Printing of medicines enables creating the structure modifications and thus controlling the drug release or combining multiple drugs into one tablet, simplifying the dose regimen. Medications printed on-demand, in health-care facilities, could address the special needs of pediatric patients and help avoid interruptions in the supply chain. Despite promising advances, the described methods have limitations and need further investigation before being scaled-up to an industrial manufacturing environment. There is also a need to establish protocols for the preparation and registration of 3DP dosage forms.
Original languageEnglish
Pages (from-to)1523-1541
Number of pages19
JournalExpert Opinion on Drug Delivery
Volume21
Issue number11
Early online date11 Dec 2023
DOIs
Publication statusPublished - 2024

Keywords

  • Mental Disorders
  • neurological disorders
  • 3D printing
  • additive manufacturing
  • solid dosage forms
  • personalised medicine

Fingerprint

Dive into the research topics of '3D-printed solid oral dosage forms for mental and neurological disorders: recent advances and future perspectives'. Together they form a unique fingerprint.

Cite this